On Thursday, GitLab Cl A got an upgrade for its IBD SmartSelect Composite Rating from 92 to 97.
The upgrade means the stock currently tops 97% of all other stocks in terms of key performance metrics and technical strength. History shows the top market performers tend to have a 95 or higher score as they launch their major climbs.
GitLab Cl A is not currently near a proper buy point. See if the stock goes on to form a new chart pattern and offer a new buying opportunity.
Lean How — And When — To Sell Stocks
One weak spot is the company's 79 EPS Rating, which tracks quarterly and annual earnings growth. Look for that to improve to 80 or better to show it's in the top 20% of all stocks.
Its Accumulation/Distribution Rating of B- shows moderate buying by institutional investors over the last 13 weeks.
In Q4, the company reported 120% EPS growth. Revenue growth fell to 29%, down from 31% in the prior quarter.
GitLab Cl A holds the No. 4 rank among its peers in the Computer-Technical Services industry group. Gorilla Technology Group is the top-ranked stock within the group.
This article was created automatically with Stats Perform's Wordsmith software using data and article templates supplied by Investor's Business Daily. An IBD journalist may have edited the article.
